Year-over-year, this metric declined by 1.8%, from $8.11B to $7.96B. Over 4 years (FY 2021 to FY 2025), Pre-Tax Income shows a downward trend with a -8.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
This provides a view of profitability that is not skewed by varying tax rates or one-time tax credits.
A company's profits before the deduction of corporate income tax. It combines operating performance with non-operating f...
Used to compare companies across different tax jurisdictions to see who generates more raw profit.
income_before_tax| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.57B | $5.29B | $5.11B | $6.52B | $6.67B | $6.95B | $6.22B | $7.33B | $7.23B | $7.69B | $6.86B | $1.00M | $5.67B | $7.61B | $6.79B | $8.11B | $4.08B | $3.23B | $0.00 | $7.96B |
| QoQ Change | — | -5.0% | -3.4% | +27.5% | +2.3% | +4.2% | -10.5% | +18.0% | -1.4% | +6.4% | -10.8% | -100.0% | >999% | +34.4% | -10.8% | +19.4% | -49.6% | -20.9% | -100.0% | — |
| YoY Change | — | — | — | — | +19.7% | +31.3% | +21.6% | +12.5% | +8.5% | +10.7% | +10.4% | -100.0% | -21.6% | -1.0% | -1.0% | >999% | -27.9% | -57.6% | -100.0% | -1.8% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Unitedhealthcare | $2.78B | $4.19B | $2.99B | $5.21B | $2.03B | $1.72B | $193.00M | $5.62B |
| Optum Health | — | — | $1.79B | — | — | — | -$2.78B | — |
| Optum Insight | — | — | $1.27B | — | — | — | $0.00 | — |
| Optum Rx | — | — | $1.74B | — | — | — | $2.89B | — |
| Total | $5.67B | $7.61B | $6.79B | $8.11B | $4.08B | $3.23B | $0.00 | $7.96B |
Optum Health, Optum Insight, Optum Rx were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.